Showing results (191-200 of 303) with videos related to

Sort By:
Pageof 31
BMJ Quality & Safety|October 26, 2019
Comparative effectiveness of risk mitigation strategies to prevent fetal exposure to mycophenolateAmir Sarayani, Yasser Albogami, Mohannad Elkhider, et al.
American Journal of Epidemiology|July 15, 2025
COVID-19 pandemic impact on clinical condition capture in real-world data: an assessment frameworkYehua Wang, Yanning Wang, Earl J Morris, et al.
Pain Medicine (Malden, Mass.)|March 10, 2021
Utilization Patterns of Skeletal Muscle Relaxants Among Commercially Insured Adults in the United States from 2006 to 2018Yan Li, Chris Delcher, Gary M Reisfield, et al.
Medical Cannabis and Cannabinoids|February 28, 2022
Proceedings of the 2021 Cannabis Clinical Outcomes Research ConferenceAmie J Goodin, Debbie L Wilson, Robert L Cook, et al.
Pharmacotherapy|May 14, 2017
Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in FloridaXi Wang, Yanmin Zhu, Chintan V Dave, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 25, 2003
Nature of preventable adverse drug events in hospitals: a literature reviewPenkarn Kanjanarat, Almut G Winterstein, Thomas E Johns, et al.
Pharmacotherapy|November 2, 2019
Concomitant Use of Quinolones and Stimulants and the Risk of Adverse Cardiovascular Symptoms: A Retrospective Cohort StudyAdel A Alrwisan, Yu-Jung J Wei, Babette A Brumback, et al.
Pharmacoepidemiology and Drug Safety|November 25, 2015
Stimulant use following the publicity of cardiovascular safety and the introduction of patient medication guidesChih-Ying Chen, Regina Bussing, Abraham G Hartzema, et al.
Pain|March 17, 2025
Unrelieved pain and risk of opioid use disorder or overdose in older adults prescribed opioidsYu-Jung Jenny Wei, Siegfried Schmidt, Roger B Fillingim, et al.
Pageof 31